Glass Health vs PERISCOPE
Glass Health sells monthly plans from $0 to $200, with Pro at $90 ad-free, Lite and Starter carrying ad sponsorships, and the EHR workflows only on Max. It started in 2021, went through Y Combinator's W23 batch and raised a $5M seed round led by Initialized Capital. The vendor lists 60-plus document types and billing suggestions with E/M, ICD-10 and CPT, and claims a knowledge base of 38M+ peer-reviewed citations.
PERISCOPE suits a hospital surgical department. Healthplus.ai trains XGBoost models for each hospital, rechecks accuracy across 16 subgroups such as sex and age, and the vendor quotes 8 to 12 weeks to implement depending on the EHR. Its EUR 2.3M late-seed round was meant for rollout in Europe, a US launch and FDA clearance. A US clinic shopping for a scribe and a surgical department buying infection-risk scoring are separate purchases with separate buyers.
Decision support · Reviewed November 2, 2026
Glass Health
by Glass Health · founded 2021
DDx plus literature-grounded A&P plus ambient scribe in one workflow.
PERISCOPE
by Healthplus.ai
PERISCOPE predicts postoperative bacterial infection risk 7 and 30 days after surgery from EHR data.
When to pick each one
Glass Health
- Pro plan $90 per month, ad-free
- Vendor lists 60-plus document types
- Max plan adds vendor-stated EHR workflows
PERISCOPE
- XGBoost models per hospital, 16-subgroup accuracy check
- Vendor quotes 8 to 12 weeks to implement
- Postoperative infection scoring, vendor-stated CE Class IIa
Score
Each row shows points earned of points available under the published rubric.
Glass Health
42of 100
PERISCOPE
15of 100
| Dimension | Glass Health | PERISCOPE | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 6 / 10 | 0 / 10 | +6 |
| EHR integrations (count) | 2.8 / 5.6 | 0 / 5.6 | +2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 3.4 / 4.8 | 0 / 4.8 | +3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 8.4 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 8.4 / 12 | 3 / 12 | +5.4 |
| Pricing transparency | 2.5 / 2.5 | 1.3 / 2.5 | +1.3 |
| Years in market | 4.2 / 6 | 0 / 6 | +4.2 |
Scroll horizontally to see every column.
Pricing
Glass Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Lite | n/a | n/a | Limited scribing and clinical decision support. Carries ad sponsorships. |
| Starter | $20 | n/a | Carries ad sponsorships. |
| Pro | $90 | n/a | Most popular tier, ad-free. |
| Max | $200 | n/a | For clinics. EHR integration (Athena, Epic, eCW, Elation) is available only on this tier. |
PERISCOPE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Glass Health
FDA decisions
No FDA decision cited in our research as of October 26, 2026.
Peer-reviewed
1 PubMed record names Glass Health.
Community
1 post sourced: 0 positive, 1 neutral, 0 negative.
PERISCOPE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
1 PubMed record names PERISCOPE.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Glass Health | PERISCOPE |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic, athenahealth, eClinicalWorks, Elation | Not specified |
| Founded | 2021 | n/a |
| HQ | US | NL |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.